Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Reduced Stx17 expression may contribute to Alopecia Areata.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Anti-Ro exposed children had more reported neuro-psychiatric issues, but differences from healthy controls were not significant.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Homeopathic treatment may help manage alopecia areata.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.